๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A note on the comparison of two different formulations of a risky R&D model

โœ Scribed by Abraham Mehrez

Publisher
Elsevier Science
Year
1983
Tongue
English
Weight
210 KB
Volume
2
Category
Article
ISSN
0167-6377

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The treatment of depression with differe
The treatment of depression with different formulations of venlafaxine: a comparative analysis
โœ James S. Olver; Graham D. Burrows; Trevor R. Norman ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 80 KB ๐Ÿ‘ 1 views

## Abstract Venlafaxine is the first of a group of antidepressants that show dual reuptake inhibition of serotonin and noradrenaline (SNRIs). Originally marketed in an immediate release (IR) formulation a microencapsulated, extended release (XR) formulation is now available. Significant differences

Direct comparison of two different mesal
Direct comparison of two different mesalamine formulations for the induction of remission in patients with ulcerative colitis: A double-blind, randomized study
โœ Hiroaki Ito; Mitsuo Iida; Takayuki Matsumoto; Yasuo Suzuki; Hidetaka Sasaki; Toy ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 131 KB ๐Ÿ‘ 2 views

Background: Mesalamine is the first-line drug for the treatment of ulcerative colitis (UC). We directly compared the efficacy and safety of two mesalamine formulations for the induction of remission in patients with UC. ## Methods: In a multicenter, double-blind, randomized study, 229 patients wit

Direct comparison of two different mesal
Direct comparison of two different mesalamine formulations for the maintenance of remission in patients with ulcerative colitis: A double-blind, randomized study
โœ Hiroaki Ito; Mitsuo Iida; Takayuki Matsumoto; Yasuo Suzuki; Yoshiyuki Aida; Toyo ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 240 KB ๐Ÿ‘ 2 views

Background: Mesalamine has been used as the first-line medication for the treatment of ulcerative colitis (UC). We directly compared the efficacy and safety of two different mesalamine formulations in the maintenance of remission in patients with UC. ## Methods: In a multicenter, double-blind, ran